TRMED — Thor Medical ASA Share News
0.000.00%
- NOK1.49bn
- NOK1.48bn
- NOK0.44m
Brief: Nordic Nanovector ASA Says merger with APIM is in best interests of shareholders
Brief: North Energy ASA Says Proposal To Merge With APIM Is Both Poorly Conceived And Not In Best Interest Of Shareholders Of Nordic Nanovector
Brief: Nordic Nanovector And APIM Therapeutics Announce Merger Agreement
Brief: Nordic Nanovector Says Board Has Been Consolidated To Conserve Resources
Nordic Nanovector shares slump with company having 'little cash at hand'
Brief: Nordic Nanovector Q2 Operating Loss Narrows To NOK 102.8 Million
Brief: Nordic Nanovector Explores Strategic Options, Changes CEO
Brief: Nordic Nanovector To Explore Strategic Options
Nordic Nanovector shares take 'final hit' as it scraps cancer drug study
Brief: Nordic Nanovector To Discontinue Paradigme, Its Phase 2B Trial With Betalutin In 3L R And R Follicular Lymphoma
Nordic Nanovector hits new record low after another blow to cancer drug trial
Brief: Nordic Nanovector To Seek Regulatory Feedback After Preliminary Review
Brief: Nordic Nanovector Presents Betalutin Data
Nordic Nanovector plummets as slow enrolment puts cancer drug trial into question
Brief: Nordic Nanovector To Conduct A Comprehensive Review
Brief: Nordic Nanovector Q1 Comprehensive Loss At NOK 105.1 Mln
Europe Research Roundup: BBVA, Provident Financial, Vivendi
Nordic Nanovector: Jefferies cuts on potential Betalutin delays, commercial challenges
Europe Research Roundup: Antofagasta, IMI, Lloyds